Abstract Coronavirus disease 2019 (COVID-19) is an infectious respiratory disorder caused
by a new coronavirus called SARS-CoV-2. The pathophysiology of severe COVID-19 is …

Objective: The increased level of interleukin (IL)-33 is considered as a predictor of severe
coronavirus disease 2019 (COVID-19) infection, but its role at different stages of the disease …

Background Severe acute respiratory syndrome caused by novel coronavirus 2 (SARS-CoV-
2) emerged in Wuhan (China) in December 2019. Here we evaluated a panel of biomarkers …

Since the outbreak of coronavirus disease 2019 (COVID-19) in Wuhan, China, it has rapidly
spread across many other countries. While the majority of patients were considered mild …

IL-33 is an alarmin that plays an integral role in lung homeostasis through its actions in
wound repair, fibrosis, and remodeling processes. 1 Stored in the nucleus, IL-33 is released …

The severity of COVID-19 is largely determined by the inflammatory response, a “Cytokine
storm,” that involves both pro-and anti-inflammatory cytokines. In the current study we …

Coronavirus SARS-CoV-2 has represented, and still represents, a real challenge from a
clinical, diagnostic and therapeutic point of view. During acute infection, the increased levels …

Background This study analyzed serum concentrations of interleukin (IL)-22 and IL-33 (pro-
inflammatory and anti-inflammatory cytokines) in 90 patients with mild/moderate coronavirus …

Objective Immune changes play fundamental roles in the pathogenesis and severity of
coronavirus disease 2019 (COVID-19). Previous studies have revealed alterations in …

Objective The hyperinflammatory response, caused by severe acute respiratory syndrome-2
(SARS-CoV-2), is the most common cause of death in patients with coronavirus disease …